<DOC>
	<DOCNO>NCT00238719</DOCNO>
	<brief_summary>To determine anxiolytic efficacy , safety , tolerability flexible-dose venlafaxine extend release ( ER ) administer 16 week treatment child adolescent outpatient social anxiety disorder ( generalize ) placebo-controlled study .</brief_summary>
	<brief_title>Study Evaluating Venlafaxine ER Children Adolescents With Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Male female outpatient 817 year old diagnosis Social Anxiety Disorder concomitant psychiatric medical disorder interfere safety assessment</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Social Anxiety</keyword>
	<keyword>Children Disorders</keyword>
</DOC>